The full content will be available shortly. Thank you for your patience!
🏠︎ » Uncategorized » Cutaneous T-cell lymphomas: diagnosis and treatment challenges in Angola and Sub-Saharan Africa
Juliano V. Isaías 1, Laurinda Jamba-Calucango 2, Lucas Chilombe-Filindo 3, Rosa Ramos 1, Alberta da Cruz-Chambi 2, Lídia P. Almeida-Voumard 4 
1 Dermatology Service, Viana General Hospital, “Bispo Emílio de Carvalho”, Icolo e Bengo, Angola; 2 Dermatology Service, General Hospital, Huambo, Angola; 3 Dermatology Service, Clinica Multiperfil Luanda, Angola; 4 Department of Medicine, Faculty of Medicine, Agostinho Neto University, Luanda, Angola
Juliano V. Isaías, Laurinda Jamba-Calucango, Lucas Chilombe-Filindo, Rosa Ramos, Alberta da Cruz-Chambi, Lídia P. Almeida-Voumard
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Lídia P. Almeida-Voumard. Email: lidiavoumard2003@yahoo.fr
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of rare diseases, for which there is little epidemiological data in Angola and Sub-Saharan Africa (SSA). Diagnosing CTCLs requires a systematic evaluation of general symptoms, skin lesions, and histological features to guide their management. Mycosis fungoides (MF) is the most common non-Hodgkin’s lymphoproliferative disease, followed by cutaneous anaplastic CD30+ large cell lymphoma (ALCL), accounting for about 2-5% of non-Hodgkin’s lymphomas. We present the clinical, histopathological, and immunohistochemical features, therapeutic approach, and outcomes of the first two well-documented cases of anaplastic lymphoma kinase-negative ALCL CD30+ and MF in Angola, illustrating the challenges for diagnosing and managing such malignant diseases in that context. A succinct literature review highlights the characteristics of these tumors in darker skin types, i.e., skin of color patients, and reports from SSA.
The full content will be available shortly. Thank you for your patience!